EverSource Wealth Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Buy |
2,004
+1,012
| +102% | +$127K | 0.01% | 759 |
|
|
2025
Q1 | $136K | Sell |
992
-456
| -31% | -$62.4K | 0.01% | 798 |
|
|
2024
Q4 | $221K | Buy |
1,448
+1,258
| +662% | +$192K | 0.01% | 620 |
|
|
2024
Q3 | $36.8K | Sell |
190
-34
| -15% | -$6.59K | ﹤0.01% | 1194 |
|
|
2024
Q2 | $47.8K | Sell |
224
-49
| -18% | -$10.4K | ﹤0.01% | 1110 |
|
|
2024
Q1 | $58.6K | Sell |
273
-222
| -45% | -$47.7K | ﹤0.01% | 911 |
|
|
2023
Q4 | $128K | Sell |
495
-25
| -5% | -$6.47K | 0.01% | 561 |
|
|
2023
Q3 | $134K | Sell |
520
-3
| -0.6% | -$771 | 0.01% | 485 |
|
|
2023
Q2 | $149K | Sell |
523
-14
| -3% | -$3.99K | 0.02% | 460 |
|
|
2023
Q1 | $149K | Sell |
537
-5
| -0.9% | -$1.39K | 0.02% | 437 |
|
|
2022
Q4 | $150K | Buy |
542
+200
| +58% | +$55.4K | 0.02% | 404 |
|
|
2022
Q3 | $92K | Buy |
342
+278
| +434% | +$74.8K | 0.02% | 449 |
|
|
2022
Q2 | $13K | Buy |
64
+20
| +45% | +$4.06K | ﹤0.01% | 951 |
|
|
2022
Q1 | $9K | Sell |
44
-67
| -60% | -$13.7K | ﹤0.01% | 1000 |
|
|
2021
Q4 | $27K | Buy |
+111
| New | +$27K | 0.01% | 563 |
|